Maintaining Investments in New Innovation Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Maintaining Investments in New Innovation Act (H.R. 5547) is a bill introduced in the 118th Congress aimed at supporting continued investment in health-related innovation. Although the official summary and full text are not available, the bill was referred to the House Subcommittee on Health, indicating its focus on health policy. The bill did not advance beyond committee and is currently classified as failed or expired.
H.R. 5547 sought to promote investment in health innovation but did not progress past the subcommittee stage and is no longer active in the 118th Congress.
- The bill is titled Maintaining Investments in New Innovation Act and relates to health policy.
- It was introduced in the House and referred to the Subcommittee on Health on December 17, 2024.
- The bill failed to advance and is currently expired, with no available full text or official summary.
Potential beneficiaries would likely include health innovation sectors, medical researchers, healthcare organizations, and possibly patients who could benefit from new health technologies, although specific beneficiaries cannot be identified due to lack of detailed bill text.
Without the full text, it is unclear what implementation challenges, costs, or oversight mechanisms the bill proposed. The absence of detailed provisions limits assessment of authority delegation or policy tradeoffs.
The bill was introduced during the 118th Congress and referred to the House Subcommittee on Health but did not advance further. Its failure to progress suggests limited legislative momentum or prioritization within the health policy agenda during this session.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
If enacted, the bill could have encouraged increased investment in health innovation, potentially accelerating development of new medical technologies. Its failure to pass may slow momentum in this area or maintain the status quo in health innovation funding.
The absence of an official summary and full bill text hinders transparency and public scrutiny. Monitoring bills that fail to advance is important to understand legislative priorities and gaps in health innovation policy. Future efforts should ensure full documentation is available to facilitate informed debate and oversight.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.